ATE277611T1 - Zusammensetzung, l-carnitin oder alkanoyl l- carnitin und langkettige alkanole enthaltend - Google Patents

Zusammensetzung, l-carnitin oder alkanoyl l- carnitin und langkettige alkanole enthaltend

Info

Publication number
ATE277611T1
ATE277611T1 AT98932504T AT98932504T ATE277611T1 AT E277611 T1 ATE277611 T1 AT E277611T1 AT 98932504 T AT98932504 T AT 98932504T AT 98932504 T AT98932504 T AT 98932504T AT E277611 T1 ATE277611 T1 AT E277611T1
Authority
AT
Austria
Prior art keywords
carnitine
alkanoyl
chain alkanols
composition containing
long chain
Prior art date
Application number
AT98932504T
Other languages
English (en)
Inventor
Claudio Cavazza
Original Assignee
Sigma Tau Ind Farmaceuti
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sigma Tau Ind Farmaceuti filed Critical Sigma Tau Ind Farmaceuti
Application granted granted Critical
Publication of ATE277611T1 publication Critical patent/ATE277611T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
    • A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
    • A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
    • A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Diabetes (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Saccharide Compounds (AREA)
AT98932504T 1997-08-01 1998-07-09 Zusammensetzung, l-carnitin oder alkanoyl l- carnitin und langkettige alkanole enthaltend ATE277611T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97RM000487A IT1294227B1 (it) 1997-08-01 1997-08-01 Composizione farmaceutica contenente l-carnitina o una alcanoil l-carnitina e alcoli alifatici a lunga catena utile per la prevenzione
PCT/IT1998/000190 WO1999006039A1 (en) 1997-08-01 1998-07-09 Composition comprising l-carnitine or an alkanoyl l-carnitine and long-chain alkanols

Publications (1)

Publication Number Publication Date
ATE277611T1 true ATE277611T1 (de) 2004-10-15

Family

ID=11405212

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98932504T ATE277611T1 (de) 1997-08-01 1998-07-09 Zusammensetzung, l-carnitin oder alkanoyl l- carnitin und langkettige alkanole enthaltend

Country Status (15)

Country Link
US (1) US6328998B1 (de)
EP (1) EP0999832B1 (de)
JP (1) JP4295429B2 (de)
KR (1) KR100530878B1 (de)
AT (1) ATE277611T1 (de)
AU (1) AU741363B2 (de)
CA (1) CA2295746C (de)
DE (1) DE69826674T2 (de)
DK (1) DK0999832T3 (de)
ES (1) ES2229514T3 (de)
IT (1) IT1294227B1 (de)
NZ (1) NZ501967A (de)
PT (1) PT999832E (de)
SI (1) SI0999832T1 (de)
WO (1) WO1999006039A1 (de)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1306178B1 (it) 1999-07-27 2001-05-30 Sigma Tau Ind Farmaceuti Uso della l-carnitina e dei suoi alcanoil derivati per la preparazionedi un medicamento utile nel trattamento del paziente affetto da
IT1306722B1 (it) * 1999-10-08 2001-10-02 Sigma Tau Healthscience Spa Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di
US7214394B2 (en) * 2002-05-31 2007-05-08 Archer-Daniels-Midland Company Policosanol compositions, extraction from novel sources, and uses thereof
US20060166951A1 (en) * 2002-05-31 2006-07-27 Archer-Daniels-Midland Company Compositions and methods for sterol isolation and purification
JP4533134B2 (ja) 2002-06-10 2010-09-01 エラン ファーマ インターナショナル，リミティド ナノ粒子ポリコサノール製剤および新規なポリコサノールの組合せ
RU2331415C2 (ru) * 2002-06-17 2008-08-20 Медести Ресерч Энд Продакшн С.Р.Л. Длинноцепочечные ненасыщенные оксигенированные соединения и их применение в области терапии, косметики и питания
US20090196914A1 (en) * 2002-11-14 2009-08-06 Optime Therapeutics, Inc. Liposomal l-carnitine
US20050232911A1 (en) * 2004-04-19 2005-10-20 Schreiber Brian D Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid
ITRM20040327A1 (it) * 2004-07-01 2004-10-01 Sigma Tau Ind Farmaceuti Uso della acetil l-carnitina per la preparazione di un medicamento per il trattamento del dolore neuropatico in pazienti diabetici.
US7615641B2 (en) * 2004-07-20 2009-11-10 Sino Pharmaceuticals Corporation Long chain aliphatic alcohol derivatives and methods of making and using same
US20070087975A1 (en) * 2005-10-17 2007-04-19 Sigma-Tau Industrie Farmaceutiche Riunite Spa Compound useful for the prevention and treatment of left ventricular hypertrophy in dialysed patients
JOP20190146A1 (ar) 2016-12-19 2019-06-18 Axcella Health Inc تركيبات حمض أميني وطرق لمعالجة أمراض الكبد
MX2020001765A (es) 2017-08-14 2020-07-29 Axcella Health Inc Composiciones de aminoacidos para el tratamiento de enfermedad hepatica.
CN112839643A (zh) 2018-06-20 2021-05-25 胺细拉健康公司 用于治疗肌肉中脂肪浸润的组合物及方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2903558C2 (de) * 1978-02-03 1994-09-01 Sigma Tau Ind Farmaceuti Verwendung von L-Carnitin
JPS6299323A (ja) * 1985-10-25 1987-05-08 Yoshihide Hagiwara 高脂血症剤
IT1196564B (it) * 1986-08-04 1988-11-16 Sigma Tau Ind Farmaceuti Impiego di acetil l-carnitina nel trattamento terapeutico delle neuropatie periferiche
US5135956A (en) * 1988-10-18 1992-08-04 The Regents Of The University Of California Method of using cytoprotective alcohols to treat neural disease and neural injury
WO1991005754A2 (fr) * 1989-10-13 1991-05-02 Medafor Derives des alcools gras a longue chaine, leurs applications, notamment en tant que molecules cytotrophiques et cytoprotectrices, et compositions pharmaceutiques les contenant
JPH05103596A (ja) * 1991-10-11 1993-04-27 Yukio Yanagimoto 陸上動物用体力増強剤及び陸上動物用飼料
JPH05103629A (ja) * 1991-10-11 1993-04-27 Yukio Yanagimoto 体力増強剤
CU22229A1 (es) * 1992-09-29 1996-01-31 Dalmer Lab Sa Policosanol, una mezcla de alcoholes alifaticos primarios superiores para hipergregabilidad plaquetaria, los accidentes isquemicos, trombosis e incluso efectividad contra ulceras gastricas quimicamente inducidas y su proceso de obtencion de la caña de azucar. el tratamiento de complicaciones ateroscleroticas tales como la
JPH05310563A (ja) * 1992-05-15 1993-11-22 Nippon Oil & Fats Co Ltd カルシトニン産生増強剤
JPH0825891B2 (ja) * 1993-06-25 1996-03-13 株式会社薬理学中央研究所 脱脂米胚芽由来のリパーゼインヒビター
US5560928A (en) * 1995-06-23 1996-10-01 Defelice; Stephen L. Nutritional and/or dietary composition and method of using the same
IT1276225B1 (it) * 1995-10-17 1997-10-27 Sigma Tau Ind Farmaceuti Composizioni farmaceutiche contenenti l-carnitina e alcanoil l- carnitine in associazione con resveratrolo o suoi derivati utili per
IT1283967B1 (it) * 1996-03-29 1998-05-07 Sigma Tau Ind Farmaceuti Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi

Also Published As

Publication number Publication date
DE69826674T2 (de) 2005-02-24
WO1999006039A1 (en) 1999-02-11
HK1028547A1 (en) 2001-02-23
KR100530878B1 (ko) 2005-11-23
ITRM970487A1 (it) 1999-02-01
IT1294227B1 (it) 1999-03-24
ES2229514T3 (es) 2005-04-16
AU741363B2 (en) 2001-11-29
SI0999832T1 (en) 2004-12-31
PT999832E (pt) 2004-12-31
US6328998B1 (en) 2001-12-11
JP4295429B2 (ja) 2009-07-15
CA2295746C (en) 2007-11-20
JP2001511447A (ja) 2001-08-14
CA2295746A1 (en) 1999-02-11
KR20010022449A (ko) 2001-03-15
EP0999832B1 (de) 2004-09-29
AU8240798A (en) 1999-02-22
DE69826674D1 (de) 2004-11-04
NZ501967A (en) 2001-09-28
EP0999832A1 (de) 2000-05-17
DK0999832T3 (da) 2005-01-17

Similar Documents

Publication Publication Date Title
ATE277611T1 (de) Zusammensetzung, l-carnitin oder alkanoyl l- carnitin und langkettige alkanole enthaltend
DE69629273D1 (de) Zusammensetzungen enthaltend Propionyl-L-Carnitine und Hydroxyzitronensäure oder Pantothensäure
DK0780124T3 (da) Farmaceutisk præparat omfattende et alkanoyl-L-carnitin sammen med en polyumættet fedtsyre fra omega-3-serien til forebyggelse og behandling af lipidmetabolisme-lidelser
PE20001325A1 (es) Combinacion de cerivastatina y fibratos
BG102733A (en) New substituted cyclic amino acids as pharmaceutical forms
BR9810121A (pt) Utilização do acido petroselìnico nativo ou esterificado
CA2086429A1 (fr) Composition pharmaceutique ou cosmetique contenant en association un retinoide et un sterol
ITMI951021A0 (it) Composizioni farmaceutiche e/o dietetiche ad attivita' antiossidante
BR9813474A (pt) Processo para intensificar uma absorção pelo animal de pelo menos um composto lipofìlico, e, composição
ATE292463T1 (de) L-carnitin oder ihre derivate und resveratrol oder ihre derivate zur vorbeugung und behandlung von kardiovaskulären erkrankungen, peripheren gefässkrankheit, peripheren diabetischen neuropathie und diese enthaltende pharmazeutische zusammensetzungen
BG109876A (en) APPLICATION OF L-CARNITIN ESTERS OR ALCANAILIC L-CARNITINES AS CATIONARY LIPIDS FOR INTRACULAR TRANSMISSION OF PHARMACOLOGICALLY ACTIVE SUBSTANCES
PT797993E (pt) Composicoes que contem l-carnitina ou os seus derivados e antioxidantes
ATE212837T1 (de) Pharmazeutische zubereitung zur behandlung akuter rhinitiden, enthaltend sympthomimeticum und pantothenol und/oder pantothensäure
PT977560E (pt) Tioesteres de ibuprofeno como inibidores de formacao de mediadores de inflamacaoe da dor dependente de nf-kb
PT795604E (pt) Estirpes de bacterias com metabolismo alterado de acidos biliares e sua utilizacao
PT1023034E (pt) Formulacoes cosmeticas para prevencao e tratamento da queda de cabelo
PT998276E (pt) Utilizacao de derivados de alcanoil carnitina para o tratamento de disturbios de defice de atencao com hiperactividade
DE60132374D1 (de) Alpha-ketoglutarate von wirkstoffen und deren zusammensetzungen
DE60002607D1 (de) Zusammensetzung zur vorbeugung und/oder behandlung von störungen aufgrund von abnormalen fettstoffmetabolismus, enthaltend l-carnitin und chitosan
ZA200005553B (en) Methods and compositions using terfenadine metabolites in combination with leukotriene inhibitors.
BG104119A (en) A new composition
FR2763795B1 (fr) Procede de preparation de vegetaux tels que les epices, les plantes aromatiques et les aromates
DK1414496T3 (da) Farmaceutisk sammensætning indeholdende en kombination af PPAR-alpha, pravastatin og mindst en polyglycoliseret glycerid
ATE363273T1 (de) Verwendung von itakonsäure zur regulierung des glykolytischen stoffwechsels
BR9812742A (pt) Processo para preparar um produto baseado em vegetal ou fruta, composição compreendendo um produto baseado em vegetal e/ou fruta, e, produto baseado por vegetal ou fruta

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0999832

Country of ref document: EP